These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38898351)

  • 1. Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma.
    León X; Valero C; Fuster G; Bragado P; Camacho M; Avilés-Jurado FX
    Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38898351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy.
    León X; Llansana A; Pérez-Ugarte L; García J; Valero C; Quer M; Camacho M
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(6):359-364. PubMed ID: 37931687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of transcriptional expression of Krüppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy.
    León X; Venegas M; Pujol A; Bulboa C; Llansana A; Casasayas M; Quer M; Camacho M
    Clin Transl Oncol; 2021 Dec; 23(12):2507-2512. PubMed ID: 34061320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.
    León X; García J; Farré N; Majercakova K; Avilés-Jurado FX; Quer M; Camacho M
    Acta Otorrinolaringol Esp (Engl Ed); 2021; 72(6):337-343. PubMed ID: 34844671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.
    León X; García J; Farré N; Majercakova K; Avilés-Jurado FX; Quer M; Camacho M
    Acta Otorrinolaringol Esp (Engl Ed); 2020 Sep; ():. PubMed ID: 32972719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy.
    Camacho M; León X; Pujol A; Montezuma L; Quer M; García J
    Clin Transl Oncol; 2022 Nov; 24(11):2175-2180. PubMed ID: 35752749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma.
    Bagué S; León X; Terra X; Lejeune M; Camacho M; Avilés-Jurado FX
    Head Neck; 2022 Nov; 44(11):2505-2512. PubMed ID: 36207788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy.
    León X; García J; Pujol A; de Juan J; Vásquez R; Quer M; Camacho M
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3679-3684. PubMed ID: 34993612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of the Sonic Hedgehog/Gli pathway transcriptional target Neogenin-1 is associated with basal cell carcinoma aggressiveness.
    Casas BS; Adolphe C; Lois P; Navarrete N; Solís N; Bustamante E; Gac P; Cabané P; Gallegos I; Wainwright BJ; Palma V
    Oncotarget; 2017 Oct; 8(48):84006-84018. PubMed ID: 29137400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of neogenin dampens hepatic ischemia-reperfusion injury.
    Schlegel M; Granja T; Kaiser S; Körner A; Henes J; König K; Straub A; Rosenberger P; Mirakaj V
    Crit Care Med; 2014 Sep; 42(9):e610-9. PubMed ID: 25029243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neogenin-1 Promotes Cell Proliferation, Motility, and Adhesion by Up-Regulation of Zinc Finger E-Box Binding Homeobox 1 Via Activating the Rac1/PI3K/AKT Pathway in Gastric Cancer Cells.
    Qu H; Sun H; Wang X
    Cell Physiol Biochem; 2018; 48(4):1457-1467. PubMed ID: 30064133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Netrin-4/ Neogenin-1 axis promotes neuroblastoma cell survival and migration.
    Villanueva AA; Falcón P; Espinoza N; R LS; Milla LA; Hernandez-SanMiguel E; Torres VA; Sanchez-Gomez P; Palma V
    Oncotarget; 2017 Feb; 8(6):9767-9782. PubMed ID: 28038459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of CD45 transcriptional expression in head and neck cancer.
    Camacho M; Agüero A; Sumarroca A; López L; Pavón MÁ; Avilés-Jurado FX; García J; Quer M; León X
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):225-232. PubMed ID: 29177949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer.
    Zhang M; Zhou Z; Pan XK; Zhou YJ; Li HO; Qiu PS; Zhang MN; Peng RY; Wang HZ; Liu L; Liu J; Zhao Q
    Cancer Cell Int; 2020; 20():510. PubMed ID: 33088218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
    Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
    Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
    Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
    Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
    Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H; Hong WK; Hittelman WN
    J Natl Cancer Inst; 1996 Apr; 88(8):519-29. PubMed ID: 8606380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.
    Valero C; Pardo L; Sansa A; Garcia Lorenzo J; López M; Quer M; León X
    Head Neck; 2020 Feb; 42(2):336-343. PubMed ID: 31750591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.